These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
453 related articles for article (PubMed ID: 19365035)
1. Effect of chitosan-N-acetylcysteine conjugate in a mouse model of botulinum toxin B-induced dry eye. Hongyok T; Chae JJ; Shin YJ; Na D; Li L; Chuck RS Arch Ophthalmol; 2009 Apr; 127(4):525-32. PubMed ID: 19365035 [TBL] [Abstract][Full Text] [Related]
2. Topical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model. Zhu L; Zhang C; Chuck RS Mol Vis; 2012; 18():1803-12. PubMed ID: 22815633 [TBL] [Abstract][Full Text] [Related]
3. Lacrimal gland inflammatory cytokine gene expression in the botulinum toxin B-induced murine dry eye model. Park CY; Zhuang W; Lekhanont K; Zhang C; Cano M; Lee WS; Gehlbach PL; Chuck RS Mol Vis; 2007 Nov; 13():2222-32. PubMed ID: 18087241 [TBL] [Abstract][Full Text] [Related]
4. Comparison of topical dry eye medications for the treatment of keratoconjunctivitis sicca in a botulinum toxin B-induced mouse model. Lekhanont K; Leyngold IM; Suwan-Apichon O; Rangsin R; Chuck RS Cornea; 2007 Jan; 26(1):84-9. PubMed ID: 17198019 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic effect of topical adiponectin in a mouse model of desiccating stress-induced dry eye. Li Z; Woo JM; Chung SW; Kwon MY; Choi JS; Oh HJ; Yoon KC Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):155-62. PubMed ID: 23211823 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model. Zhu L; Shen J; Zhang C; Park CY; Kohanim S; Yew M; Parker JS; Chuck RS Mol Vis; 2009; 15():250-8. PubMed ID: 19190733 [TBL] [Abstract][Full Text] [Related]
7. Effect of 0.025% FK-506 eyedrops on botulinum toxin B-induced mouse dry eye. Lin BW; Chen MZ; Fan SX; Chuck RS; Zhou SY Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):45-53. PubMed ID: 25491293 [TBL] [Abstract][Full Text] [Related]
8. Effects of topical anti-inflammatory agents in a botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. Lekhanont K; Park CY; Smith JA; Combs JC; Preechawat P; Suwan-Apichon O; Rangsin R; Chuck RS J Ocul Pharmacol Ther; 2007 Feb; 23(1):27-34. PubMed ID: 17341147 [TBL] [Abstract][Full Text] [Related]
9. [Therapeutic effects of Pyranoprofen on the mouse dry eye induced by topical medication of Benzalkonium Chloride]. He H; Liu ZG; Lin ZR; Liu XC; He H; Xiao QG Zhonghua Yan Ke Za Zhi; 2012 Jan; 48(1):33-40. PubMed ID: 22490914 [TBL] [Abstract][Full Text] [Related]
10. Modulation of integrin alpha4beta1 (VLA-4) in dry eye disease. Ecoiffier T; El Annan J; Rashid S; Schaumberg D; Dana R Arch Ophthalmol; 2008 Dec; 126(12):1695-9. PubMed ID: 19064851 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-1 receptor-1-deficient mice show attenuated production of ocular surface inflammatory cytokines in experimental dry eye. Narayanan S; Corrales RM; Farley W; McDermott AM; Pflugfelder SC Cornea; 2008 Aug; 27(7):811-7. PubMed ID: 18650668 [TBL] [Abstract][Full Text] [Related]
12. Effectiveness of topical infliximab in a mouse model of experimental dry eye. Li Z; Choi W; Oh HJ; Yoon KC Cornea; 2012 Nov; 31 Suppl 1():S25-31. PubMed ID: 23038030 [TBL] [Abstract][Full Text] [Related]
13. Effects of Topical Mucolytic Agents on the Tears and Ocular Surface: A Plausible Animal Model of Mucin-Deficient Dry Eye. Li X; Kang B; Woo IH; Eom Y; Lee HK; Kim HM; Song JS Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3104-3114. PubMed ID: 30025127 [TBL] [Abstract][Full Text] [Related]
14. Comparison of 0.025% FK-506, 0.05% Cyclosporin A, and 0.3% Sodium Hyaluronate Eye Drops for the Treatment of Botulinum Toxin B-Induced Mouse Dry Eye. Lin BW; Huang WL; Wang L; Chen ZM J Ocul Pharmacol Ther; 2018 Nov; 34(9):633-641. PubMed ID: 30227093 [TBL] [Abstract][Full Text] [Related]
15. Effect of topical olopatadine and epinastine in the botulinum toxin B-induced mouse model of dry eye. Lekhanont K; Park CY; Combs JC; Suwan-Apichon O; Rangsin R; Chuck RS J Ocul Pharmacol Ther; 2007 Feb; 23(1):83-8. PubMed ID: 17341156 [TBL] [Abstract][Full Text] [Related]
16. Experimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surface. Luo L; Li DQ; Doshi A; Farley W; Corrales RM; Pflugfelder SC Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4293-301. PubMed ID: 15557435 [TBL] [Abstract][Full Text] [Related]
17. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Rashid S; Jin Y; Ecoiffier T; Barabino S; Schaumberg DA; Dana MR Arch Ophthalmol; 2008 Feb; 126(2):219-25. PubMed ID: 18268213 [TBL] [Abstract][Full Text] [Related]
18. Antioxidant and inflammatory cytokine in tears of patients with dry eye syndrome treated with preservative-free versus preserved eye drops. Jee D; Park SH; Kim MS; Kim EC Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5081-9. PubMed ID: 24994869 [TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca. Suwan-apichon O; Rizen M; Rangsin R; Herretes S; Reyes JM; Lekhanont K; Chuck RS Invest Ophthalmol Vis Sci; 2006 Jan; 47(1):133-9. PubMed ID: 16384954 [TBL] [Abstract][Full Text] [Related]
20. Effects of eye drops containing a mixture of omega-3 essential fatty acids and hyaluronic acid on the ocular surface in desiccating stress-induced murine dry eye. Li Z; Choi JH; Oh HJ; Park SH; Lee JB; Yoon KC Curr Eye Res; 2014 Sep; 39(9):871-8. PubMed ID: 24559509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]